Financial reports
10-K
2023 FY
Annual report
18 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
24 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
11 Mar 22
Current reports
8-K
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
18 Mar 24
8-K
Other Events
23 Jan 24
8-K
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study
16 Jan 24
8-K
Other Events
12 Dec 23
8-K
Leap Therapeutics Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Other Events
13 Sep 23
8-K
Leap Therapeutics Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
Leap Therapeutics Announces Initiation of Randomized Controlled Part B
12 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 23
8-K
Leap Therapeutics Announces Reverse Stock Split
20 Jun 23
Registration and prospectus
S-3
Shelf registration
18 Mar 24
S-8
Registration of securities for employees
26 Jan 24
S-8
Registration of securities for employees
30 Aug 23
424B3
Prospectus supplement
14 Jun 23
S-3/A
Shelf registration (amended)
9 Jun 23
S-3
Shelf registration
21 Apr 23
D
$77.22 mm in equity / options, sold $77.22 mm, 121 investors
13 Mar 23
S-8
Registration of securities for employees
6 Feb 23
S-8
Registration of securities for employees
17 Aug 22
S-8
Registration of securities for employees
28 Jan 22
Proxies
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
24 Mar 23
DEFA14A
Additional proxy soliciting materials
23 Jan 23
DEFA14A
Additional proxy soliciting materials
17 Jan 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
11 Jun 20
Other
EFFECT
Notice of effectiveness
15 Jun 23
CORRESP
Correspondence with SEC
12 Jun 23
UPLOAD
Letter from SEC
27 Apr 23
EFFECT
Notice of effectiveness
19 Oct 20
CORRESP
Correspondence with SEC
14 Oct 20
UPLOAD
Letter from SEC
23 Sep 20
EFFECT
Notice of effectiveness
9 Aug 19
CORRESP
Correspondence with SEC
6 Aug 19
UPLOAD
Letter from SEC
6 Aug 19
UPLOAD
Letter from SEC
10 Aug 18
Ownership
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
4
Nissim Mashiach
31 Jan 24
4
Thomas John Dietz
31 Jan 24
4
Richard Schilsky
31 Jan 24
4
Christine Granfield
31 Jan 24
4
Jason Baum
31 Jan 24
4
Christian M Richard
31 Jan 24
4
John Mark O'Mahony
31 Jan 24
4
Cynthia Sirard
31 Jan 24
4
Patricia A. Martin
31 Jan 24